Cell & Gene Therapy Innovation Speaker
Strategic Marketing Manager
Michael Kapinsky is a chemist by training. In 2002 he received his PhD in the field of atherosclerosis at the Institute of Laboratory Medicine of the University of Regensburg/Germany. Following his passion for flow cytometry, he joined Beckman Coulter starting as field application support in Germany. Since 2012 he contributes to the companies flow cytometry product strategy owning global responsibilities for Beckman’s clinical research product line branded as DURAClone.